OBJECTIVES: Streptococcus pneumoniae is the leading cause of bacterial pneumonia and associated bacteremia during HIV infection. Rapid diagnostic assays may limit inappropriate therapy. METHODS: Clinical signs and symptoms and sera and urine were collected prospectively from 70 adults with pneumococcal pneumonia, including 47 with HIV co-infection. Pneumococcal C-polysaccharide antigen was detected in urine using the Binax immunochromatographic test (ICT). A systematic review of 24 published studies was conducted. RESULTS: Clinical symptoms, signs, and laboratory parameters except leukocytosis, were similar in HIV-infected and HIV-seronegative pneumonia. The performance of the urine antigen ICT was independent of HIV-status (sensitivity 81%, specificity 98%, positive (PPV) and negative predictive values (NPV) 98%, and 82%, respectively). The sensitivity of sputum Gram's stain was 58% (34/59) with sputum unable to be provided by 16%. The CRP response was identical in HIV-infected (mean+/-SD) 133+/-88 vs. seronegative 135+/-104 mg/L (p=0.9). In the systematic review, the ICT performance revealed 74% sensitivity (95% CI 72-77%) and 94% specificity (95% CI 93-95%). Urine antigen testing increases etiologic diagnosis by 23% (range: 10-59%) when testing adults with community acquired pneumonia of unknown etiology. CONCLUSIONS: Urinary antigen detection provides a credible rapid diagnostic test for pneumococcal pneumonia regardless of HIV-status. CRP response to acute infection is similar in HIV co-infection and increases diagnostic certainty.
OBJECTIVES:Streptococcus pneumoniae is the leading cause of bacterial pneumonia and associated bacteremia during HIV infection. Rapid diagnostic assays may limit inappropriate therapy. METHODS: Clinical signs and symptoms and sera and urine were collected prospectively from 70 adults with pneumococcal pneumonia, including 47 with HIV co-infection. Pneumococcal C-polysaccharide antigen was detected in urine using the Binax immunochromatographic test (ICT). A systematic review of 24 published studies was conducted. RESULTS: Clinical symptoms, signs, and laboratory parameters except leukocytosis, were similar in HIV-infected and HIV-seronegative pneumonia. The performance of the urine antigen ICT was independent of HIV-status (sensitivity 81%, specificity 98%, positive (PPV) and negative predictive values (NPV) 98%, and 82%, respectively). The sensitivity of sputum Gram's stain was 58% (34/59) with sputum unable to be provided by 16%. The CRP response was identical in HIV-infected (mean+/-SD) 133+/-88 vs. seronegative 135+/-104 mg/L (p=0.9). In the systematic review, the ICT performance revealed 74% sensitivity (95% CI 72-77%) and 94% specificity (95% CI 93-95%). Urine antigen testing increases etiologic diagnosis by 23% (range: 10-59%) when testing adults with community acquired pneumonia of unknown etiology. CONCLUSIONS: Urinary antigen detection provides a credible rapid diagnostic test for pneumococcal pneumonia regardless of HIV-status. CRP response to acute infection is similar in HIV co-infection and increases diagnostic certainty.
Authors: Davidson H Hamer; Josefina Egas; Bertha Estrella; William B MacLeod; Jeffrey K Griffiths; Fernando Sempértegui Journal: Clin Infect Dis Date: 2002-02-27 Impact factor: 9.079
Authors: Félix Gutiérrez; Mar Masiá; J Carlos Rodríguez; Antonio Ayelo; Bernardo Soldán; Laura Cebrián; Carlos Mirete; Gloria Royo; Alberto M Hidalgo Journal: Clin Infect Dis Date: 2003-01-15 Impact factor: 9.079
Authors: Werner C Albrich; Michael W Pride; Shabir A Madhi; Jan Callahan; Peter V Adrian; Roger French; Nadia van Niekerk; Shite Sebastian; Victor Souza; Jean-Noel Telles; Glaucia Paranhos-Baccalà; Kathrin U Jansen; Keith P Klugman Journal: J Clin Microbiol Date: 2016-12-28 Impact factor: 5.948
Authors: H C Baggett; J Rhodes; S Dejsirilert; P Salika; T Wansom; P Jorakate; A Kaewpan; S J Olsen; S A Maloney; L F Peruski Journal: Eur J Clin Microbiol Infect Dis Date: 2011-08-07 Impact factor: 3.267
Authors: Ray Borrow; Elaine Stanford; Pauline Waight; Matthew Helbert; Paul Balmer; Rosalind Warrington; Mary Slack; Robert George; Elizabeth Miller Journal: Infect Immun Date: 2008-09-08 Impact factor: 3.441
Authors: Seyi D Eletu; Carmen L Sheppard; Elizabeth Thomas; Kenneth Smith; Priya Daniel; David J Litt; Wei Shen Lim; Norman K Fry Journal: Clin Vaccine Immunol Date: 2017-12-05
Authors: Lee M Hampton; Godfrey Bigogo; Geofrey Jagero; Maria da Gloria Carvalho; Fabiana Pimenta; Muthoni Junghae; Robert F Breiman; Cynthia G Whitney; Daniel R Feikin; Laura M Conklin Journal: Diagn Microbiol Infect Dis Date: 2016-05-06 Impact factor: 2.803